Immunotherapy for Parkinson’s disease

With the increasing prevalence of Parkinson’s disease (PD), there is an immediate need to interdict disease signs and symptoms. In recent years this need was met through therapeutic approaches focused on regenerative stem cell replacement and alpha-synuclein clearance. However, neither have shown lo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurobiol Dis
Hauptverfasser: Schwab, Aaron D., Thurston, Mackenzie J., Machhi, Jatin, Olson, Katherine E., Namminga, Krista L., Gendelman, Howard E., Mosley, R. Lee
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933730/
https://ncbi.nlm.nih.gov/pubmed/31978602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2020.104760
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge